Education and technology sectors lead the way, while healthcare and financial services lag behind ControlUp Windows 11 ...

Cancer patients’ journeys are complex and the benefit of a drug goes well beyond survival, even in cases of incurable and/or ...

Primary and secondary end points were demonstrated in a phase 3 trial of subcutaneous marstacimab as treatment for patients ...

Action1, a leading provider of autonomous endpoint management (AEM) solutions, today announced Action1 for MSPs, a comprehensive patch management platform designed for the unique needs of managed ...

The trial’s primary goal was to assess the change in the number of migraine days per month from baseline over the first four ...

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced statistically significant data from the 16-week ...

Intermediate tumor burden–based end points, such as progression-free survival (PFS), may evaluate clinically meaningful treatment effects more efficiently and have supported the regulatory approval of ...

Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...

In this Opinion article, the authors suggest that more extensive use of laboratory measurements could help to expedite clinical trials of immunotherapy. They propose that surrogate end points ...

Treatment end points The ideal end point of therapy is sustained HBsAg loss with or without seroconversion to anti-HBs. It is associated with complete and definitive remission of the activity and ...

The implementation of a 3-year structured exercise program after completion of surgery and adjuvant chemotherapy resulted in improved disease-free survival, overall survival, patient-reported physical ...